Skip to main content
Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
5.17
+0.17 (3.40%)
At close: Mar 6, 2026, 4:00 PM EST
8.05
+2.88 (55.71%)
After-hours: Mar 6, 2026, 7:59 PM EST

Atara Biotherapeutics Revenue

Atara Biotherapeutics had revenue of $3.45M in the quarter ending September 30, 2025, a decrease of -91.41%. This brings the company's revenue in the last twelve months to $151.93M, up 51.27% year-over-year. In the year 2024, Atara Biotherapeutics had annual revenue of $128.94M with 1,404.02% growth.

Revenue (ttm)
$151.93M
Revenue Growth
+51.27%
P/S Ratio
0.25
Revenue / Employee
$3,998,158
Employees
38
Market Cap
37.28M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024128.94M120.37M1,404.02%
Dec 31, 20238.57M-55.00M-86.51%
Dec 31, 202263.57M43.23M212.55%
Dec 31, 202120.34M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Xilio Therapeutics 31.80M
NovaBay Pharmaceuticals 10.30M
CervoMed 6.16M
Lisata Therapeutics 1.07M
Actinium Pharmaceuticals 90.00K
INmune Bio 50.00K
Revenue Rankings

ATRA News

More News